Please login to the form below

Not currently logged in
Email:
Password:

Innate Pharma

This page shows the latest Innate Pharma news and features for those working in and with pharma, biotech and healthcare.

Inside the patient-centricity bubble

Inside the patient-centricity bubble

The hybrid model. However, ringing true to pharma, innovation comes at a price. ... Making an innate plea to pharma, he urged the industry to “stop thinking binary”.

Latest news

  • Bad news for Innate Pharma as BMS-backed drug stumbles Bad news for Innate Pharma as BMS-backed drug stumbles

    Bad news for Innate Pharma as BMS-backed drug stumbles. Lirilumab combination fails to show additional benefit in SCCHN patients. ... French biotech Innate Pharma says it can’t see a development path forward for its lead cancer drug lirilumab after

  • Sanofi and Novartis snap up immuno-oncology candidates Sanofi and Novartis snap up immuno-oncology candidates

    Now, the French pharma firm has added a 400m collaboration with Innate Pharma to develop bi-specific (double-headed) antibodies that will target both tumour antigens and NKp46, an activating receptor

  • Former Sanofi SVP Gilles Brisson to chair Mauna Kea

    Most recently, Brisson has held the position of chair at Innate Pharma since 2007 and Ethypharm since 2009.

  • HCV hope on the horizon

    US. Others in phase II trials are the T-lymphocyte stimulants GI 5005 (Tarmogen; GlobeImmune), a recombinant yeast product, and IPH 1101 (Phosphostim; Innate Pharma), a small molecule compound that is ... Romark Laboratories has a small molecule signal

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    and Innate Pharma (IPH53) – both of which work by blocking immunosuppressive mechanisms in the tumour microenvironment. ... up innate immune responses, and Cancer Research UK is repurposing an AZ chemokine CCR4 receptor drug (AZD2098) originally

  • Deal Watch January 2016 Deal Watch January 2016

    The second deal closed by Sanofi was with Innate Pharma to create new bispecific antibodies, which aim to kill tumour cells through the activation of NKp46. ... 502.3. Innate Pharma/ Sanofi. Collaboration . Collaboration to develop 2 bispecific NK cell

  • Medius Deal Watch table for April 2015 Medius Deal Watch table for April 2015

    Gene therapy platform - CV diseases. 2, 300. Innate Pharma / AstraZeneca. ... 225. Intec Pharma/ Undisclosed Company. R&D collaboration plus option. Accordian Pill (gastro retentive delivery system).

  • Pharma deals in April 2015 Pharma deals in April 2015

    Pharma deals in April 2015. The love affair with oncology continues, finds Medius Deal Watch. ... Continuing to build the oncology portfolio and looking to score a win with a combination therapy, AZ in-licensed Innate Pharma's IPH2201 for both

  • Deal Watch table for February 2014 Deal Watch table for February 2014

    For an indepth analysis of these deals, read'Pharma deals during February 2014'. ... 39. Novo Nordisk / Innate Pharma. Licence with equity partial payment.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Former AZ oncology head joins Innate Pharma Former AZ oncology head joins Innate Pharma

    Dr Mondher Mahjoubi, formerly AstraZeneca's head of oncology, has moved to lead French biotech Innate Pharma. ... Building on a unique and differentiated expertise in innate immunity, Innate Pharma has been a pioneer in immuno-oncology. “

  • Creabilis names Catherine Moukheibir as chairman of the board Creabilis names Catherine Moukheibir as chairman of the board

    Creabilis names Catherine Moukheibir as chairman of the board. She has previously held roles at Ablynx, Movetis and Innate Pharma. ... Ablynx and member of the management board at Innate Pharma.

  • Novo's Wagtmann joins Innate as chief scientific officer Novo's Wagtmann joins Innate as chief scientific officer

    Innate Pharma has appointed former Novo Nordisk VP Dr Nicolai Wagtmann as chief scientific officer. ... My team at Novo Nordisk has enjoyed very productive interactions with Innate Pharma during a multi-year research collaboration which resulted in three

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics